An emailed statement from Mercy Medical Center said the trauma designation update does not change the quality of care ...

Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN ...

A slight slide in employee engagement across health care providers nationwide could be the canary in the coal mine predicting ...

Many of America’s wealthiest business leaders have lost millions — if not billions — of dollars in net worth since the start ...

Tempus AI expands deals with AstraZeneca and Pathos for $200M, Avidicure raises $50M seed round, Bioxodes reports Phase 2a ...

Analysts are estimating that Avantor will report an earnings per share (EPS) of $0.23. Avantor bulls will hope to hear the ...

Before we get into Thursday’s column, be sure to read my colleague Sri’s story on OpenAI’s revenue forecasts. The projections ...

Medical Properties Trust, Inc. today announced it will host a conference call and webcast on Thursday, May 1, 2025 at 11:00 a.m. Eastern Time to discuss the company's first quarter 2025 financial ...

Berger Montague PC advises investors that a securities class action lawsuit has been filed against BigBear.ai Holdings, Inc. ("BigBear" or the "Company") on behalf of purchasers of BigBear securities ...

In 2023, the portfolio returned 65% vs. the S&P 500’s 24%. 2024 gains were at 54% and outperformed the broader market and top ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...